InvestorsHub Logo
Followers 35
Posts 3745
Boards Moderated 0
Alias Born 02/13/2013

Re: belgiumsui post# 23945

Saturday, 01/23/2016 10:13:44 AM

Saturday, January 23, 2016 10:13:44 AM

Post# of 118383
FANTASTIC ARTICLE!!!!! This article supports mostly why I have been invested in this from the start. A rare approach to biotech. Also this tidbit is in the article


"Regen is a public company so it can raise money in the capitol markets, a fact that could soon be lucrative for the local biotech firm.

“We believe that sometime in the first half of 2016 we should have an IND filed on our small molecule and companies with an IND filed tend to be worth north of half a billion dollars.” "

And this


“Ideally, designing some of these new immuno-oncology drugs that are actually small molecules would be sort of a Holy Grail for the insurance companies; for biopharma; and for the patients,” said Lander. “If we can develop a drug that is as effective or more effective than the current biologics –– that is small molecule and therefore much cheaper –– that would be wonderful. People would have access to it all over the world and not just the United States.”


http://lamesacourier.com/la-mesas-atypical-biotech-firm/